Press releaseBusiness Wire
Estrella Immunopharma
ESLAW · NASDAQ
$0.0799+$0.0117 (+17.16%)TodayMarket closed ·
Prev close $0.0682
ESLAW key statistics
- Market cap
- —
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 590
- Volume
- 15.12K
- Open price
- $0.08
- High today
- $0.08
- Low today
- $0.07
- 52 Week high
- $0.24
- 52 Week low
- $0.05
Estrella Immunopharma (ESLAW) at a glance
As of Oct 23, 2026, Estrella Immunopharma (ESLAW) shares are priced at $0.0799, giving the company a price-to-earnings ratio of 0.00.
Today the stock has traded between $0.07 and $0.08. The current price is 14.1% above the day's low and 0.1% below its high.
Volume so far is 15.12K shares, above the average of 590 shares a day.
Over the past year Estrella Immunopharma has ranged from $0.05 to $0.24, and now sits 16% of the way up that range.
ESLAW news
- Press releaseBusiness Wire
Estrella Immunopharma to Participate in the D. Boral Capital Global Conference
- Press releaseBusiness Wire
Estrella Immunopharma, Inc. (NASDAQ: ESLA) Receives Initiating Coverage with a Valuation of $12.00/Share from Zacks Small-Cap Research
- Press releaseBusiness Wire
Estrella Immunopharma Presents Promising Updated Data on EB103 in Oral Presentation at the 2026 Tandem Meetings of ASTCT® & CIBMTR®
- Press releaseBusiness Wire
Estrella Immunopharma Announces Closing of $8.0 Million Registered Direct Offering and Concurrent Private Placement
- Press releaseBusiness Wire
Estrella Immunopharma Completes First Dose Cohort in STARLIGHT-1 Trial and Receives Approval to Initiate Higher Dose Cohort
- Press releaseBusiness Wire
Estrella Immunopharma, Inc. (NASDAQ: ESLA; ESLAW) Receives Buy Rating with a 12-Month Price Target of $16.00 from D. Boral Capital
- Press releaseBusiness Wire
Estrella Immunopharma Achieves Complete Response in First Patient Treated with CD19- Redirected ARTEMIS® T-cells
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0002+0.00%
- GTVHGolden Triangle Ventures$0.0002+100.00%
- TMSHTrans Global Assets$0.0003+20.00%
- RDARRaadr$0.0002+0.00%
- GPUSHyperscale Data$0.1689+34.05%
- SEIISharing Economy International$0.0002−33.33%
- ELMEElme Communities$1.77+0.57%
- SHFSSHF Holdings$0.1324−61.39%
- XXII22nd Century Group$0.1977−8.34%
- NBNDNetBrands$0.0006−40.00%
- NVDGraniteShares ETF Trust$4.19+0.96%
- HIRUHiru$0.0006+9.09%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.49−0.10%
- CTYCITY THERAPEUTICS$20.77+0.00%
- IAMIambic Therapeutics$14.26−2.79%
- AMROAmaero$5.84+7.75%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.30+0.29%
- TRXBTRex Bio$13.81−10.90%
- RTSNRetension Pharmaceuticals$15.25−1.61%
- PAXGUPine Tree Acquisition$10.01+0.05%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.13−0.77%
- ACCVAccelevation Holdings$12.38+1.06%
- RZAIROZE AI$10.92−1.89%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.